z-logo
open-access-imgOpen Access
Effect of Androstenedione Ingestion on Plasma Testosterone in Young Women; a Dietary Supplement with Potential Health Risks
Author(s) -
Andrew T. Kicman,
Thomas Bassindale,
David Cowan,
Sian Dale,
Andrew J. Hutt,
Anthony Leeds
Publication year - 2003
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/49.1.167
Subject(s) - androstenedione , testosterone (patch) , endocrinology , medicine , ingestion , lean body mass , plasma concentration , androgen , oral administration , chemistry , body weight , hormone
Androstenedione is readily available as a “dietary supplement” and can be sold without restriction in most countries, including the US and UK. Manufacturers market androstenedione as a “prohormone” that can increase blood testosterone concentration, thereby increasing lean body mass and strength. It is available in capsules purported to contain 50, 100, or 300 mg of the steroid, and the manufacturers suggest that the “desired” effects can be gained by taking 100–300 mg/day orally. However, a single dose of 100 mg/day is insufficient to increase serum testosterone concentrations in men (1)(2)(3)(4). Even with higher “recommended” doses of either 200 or 300 mg/day (given as either single or multiple administrations), no significant increase has been observed in most studies (1)(3)(5), albeit in one investigation, 4 of 14 men had testosterone concentrations that exceeded the reference interval (2). The contribution of these administered amounts of androstenedione to the plasma testosterone concentration appears to be relatively small compared with the large amount of testosterone secreted by the testes.No comprehensive study has been reported regarding the effect of oral androstenedione administration on plasma testosterone in women. However, there is an indication that it can be increased considerably, based on limited data from two women, obtained by a methodology based on paper chromatography and conversion of androgens to estrogens for fluorometric analysis (6). The plasma concentration of testosterone in women of a reproductive age is ∼1/10th that found in men, and the proportion arising from peripheral conversion is much greater (7). Although ∼14% of androstenedione in blood is converted peripherally to testosterone in both men and women, the amount converted accounts for approximately one-half the circulating testosterone in the female (7)(8). Hence, ingestion of even a single 100 mg capsule of androstenedione is …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom